Ibrexafungerp citrate is under clinical development by GSK and currently in Phase III for Histoplasmosis. According to GlobalData, Phase III drugs for Histoplasmosis does not have sufficient ...

On the basis of the results of several clinical trials, the 2000 Infectious Diseases Society of America guidelines for the management of CM [47] recommended a combination of AmB (0.7–1 mg/kg/day ...

Results: A total of three RCTs involving 1,368 participants (four antifungals) were included. The NMA showed that compared to amphotericin B deoxycholate (D-AmB), the triazoles (posaconazole (POS), ...

Send your kids to these sites to help them learn, study, indulge their curiosity, and get a fresh perspective on academic subjects. I've been contributing to PCMag since 2011 in a variety of ways ...